- Home
- ALLT vs CCCC Comparison
ALLT vs CCCC Comparison
Compare ALLT & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLT
- CCCC
- Stock Information
- Founded
- ALLT 1996
- CCCC 2015
- Country
- ALLT Israel
- CCCC United States
- Employees
- ALLT N/A
- CCCC N/A
- Industry
- ALLT Telecommunications Equipment
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- ALLT Telecommunications
- CCCC Health Care
- Exchange
- ALLT Nasdaq
- CCCC Nasdaq
- Market Cap
- ALLT 342.5M
- CCCC 175.1M
- IPO Year
- ALLT 2006
- CCCC 2020
- Fundamental
- Price
- ALLT $9.41
- CCCC $3.41
- Analyst Decision
- ALLT Buy
- CCCC Strong Buy
- Analyst Count
- ALLT 1
- CCCC 3
- Target Price
- ALLT N/A
- CCCC $8.67
- AVG Volume (30 Days)
- ALLT 569.0K
- CCCC 1.3M
- Earning Date
- ALLT 08-14-2025
- CCCC 10-30-2025
- Dividend Yield
- ALLT N/A
- CCCC N/A
- EPS Growth
- ALLT N/A
- CCCC N/A
- EPS
- ALLT N/A
- CCCC N/A
- Revenue
- ALLT $95,342,000.00
- CCCC $34,240,000.00
- Revenue This Year
- ALLT $10.64
- CCCC N/A
- Revenue Next Year
- ALLT $15.76
- CCCC N/A
- P/E Ratio
- ALLT N/A
- CCCC N/A
- Revenue Growth
- ALLT 4.74
- CCCC 16.55
- 52 Week Low
- ALLT $2.78
- CCCC $1.09
- 52 Week High
- ALLT $10.77
- CCCC $7.14
- Technical
- Relative Strength Index (RSI)
- ALLT 68.01
- CCCC 70.84
- Support Level
- ALLT $8.94
- CCCC $2.58
- Resistance Level
- ALLT $9.58
- CCCC $3.65
- Average True Range (ATR)
- ALLT 0.42
- CCCC 0.23
- MACD
- ALLT 0.14
- CCCC 0.06
- Stochastic Oscillator
- ALLT 91.75
- CCCC 81.82
About ALLT Allot Ltd.
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. The company has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.